A 1259 (see companion bill S 249) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Requires pharmacy benefits manager providing services within Medicaid program to disclose certain information to DHS. It is the sponsor’s goal that such transparency will help the State to assess the magnitude in which pharmacy benefits …
A 1396 (see companion bill S 3762) – New York
Introduced: 2021 Status: Enacted
Provides for pharmacy benefit management and the procurement of prescription drugs to be dispensed to patients, or the administration or management of prescription drug benefits; sets forth definitions; provides for funds received by a pharmacy …
A 1477 (see companion bill S 1142) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Establishes Prescription Drug Review Commission; requires production costs be reported for certain prescription drugs.
A 15 (see companion bill S 5782) – New York
Introduced: 2017 Status: Inactive / Dead
PAYMENT OF BILLS FOR PHARMACEUTICAL SERVICES: If an employer shall have notified the pharmacist in writing, as provided in subdivision one of this section, why the bill has not been paid, in part or in …
A 1534 (see companion bill S 1167) – New Jersey
Introduced: 2022 Status: In Process
Establishes Prescription Drug Review Commission; requires production costs be reported for certain prescription drugs.
A 1669 – New Jersey
Introduced: 2020 Status: Inactive / Dead
Requires health insurers to limit copayments for insulin.
A 1707 (see companion bill S 599) – New York
Introduced: 2023 Status: In Process
Requires certain manufacturers of prescription drugs to notify the superintendent of any proposed increase of the wholesale acquisition cost of such prescription drugs.
A 1745 (see companion bill S 334) – New Jersey
Introduced: 2022 Status: In Process
This bill requires carriers to pass prescription drug savings on to consumers. The bill provides that all compensation paid by a pharmaceutical manufacturer to a pharmaceutical benefits manager as a result of negotiations of a …
A 1747 (see companion bill S 329) – New Jersey
Introduced: 2022 Status: In Process
This bill establishes the Prescription Drug Affordability Board (Board), which will be charged with protecting New Jersey residents, State and local governments, health benefits plans, health care providers, licensed pharmacies, and other stakeholders within the …
A 1845 – New Jersey
Introduced: 2022 Status: In Process
Limits amount paid by covered persons for purchase of insulin drugs and epinephrine; requires Division of Consumer Affairs to investigate insulin prices.
A 2222 (see companion bill S 1423) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Requires carriers to pass prescription drug savings to consumers.
A 2240 (see companion bill S 1667) – New Jersey
Introduced: 2022 Status: In Process
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.
A 2333 – New Jersey
Introduced: 2020 Status: Inactive / Dead
Establishes three-year Medicaid demonstration project to pay for certain drugs according to value-based system. Under the bill, the Department of Human Services will establish a three-year demonstration project to employ value-based payment systems for a …
A 2340 – New York
Introduced: 2021 Status: In Process
Requires pharmacies to provide customers directly with the retail (before insurance) price of a prescription, in writing and electronically prior to purchase.
A 2418 (see companion bill S 1066) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Establishes Prescription Drug Affordability Board; appropriates $1,000,000. *
A 2488 (see companion bill S 919) – New Jersey
Introduced: 2020 Status: Inactive / Dead
Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.